Articles tagged with “biologics”

2027 Drug Patent Expirations: LOE Calendar & Pipeline

Analyze 2027 drug patent expirations and the impending patent cliff. Review a detailed loss-of-exclusivity (LOE) calendar for biologics and small molecules.

25 min read

4/30/2026

drug patent expirations loss of exclusivity 2027 patent cliff loe calendar biosimilars generic drugs pharma pipeline biologics

AI Antibody Discovery: Merck-Infinimmune Deal Analysis

Analyze the $838M Merck-Infinimmune AI antibody discovery deal. Understand how the Anthrobody screening platform and GLIMPSE language model engineer biologics.

25 min read

4/18/2026

ai antibody discovery protein language models biologics machine learning memory b cells anthrobody platform glimpse model drug development

Biologics Comparability: A Guide to ICH Q5E & CMC Changes

An educational guide to biologics comparability studies. Learn how to prove "no meaningful change" after manufacturing process changes, based on ICH Q5E and FDA

50 min read

1/6/2026

comparability study biologics ich q5e cmc manufacturing changes regulatory affairs analytical characterization post-approval changes

PLLR for Biologics: Drafting Clear Pregnancy Risk Summaries

Learn how the FDA's PLLR replaced old pregnancy categories. Updated 2026 guide on drafting clear pregnancy risk summaries for biologics, with ICH E21, IMPACT trial, and PIANO registry data.

55 min read

11/23/2025

pllr pregnancy risk summary biologics fda labeling drug safety regulatory affairs monoclonal antibodies medical writing

Global Pharmaceutical Market: 2025 Analysis & Key Trends

A detailed analysis of the global pharmaceutical market, forecast to reach $1.6T by 2025. Explore key growth drivers, therapy areas, and industry challenges.

135 min read

10/14/2025

pharmaceutical industry pharma market analysis specialty medicine biologics oncology market drug pricing patent cliff pharmerging markets